CORC

在结果中检索

CORC

浏览/检索结果: 共23条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen 期刊论文
FRONTIERS IN IMMUNOLOGY, 2019, 卷号: 10
作者:  Timmers, Marijke;  Roex, Gils;  Wang, Yuedi;  Campillo-Davo, Diana;  Van Tendeloo, Viggo F., I
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05
EGFR-specific CAR-T cells trigger cell lysis in EGFR-positive TNBC 期刊论文
Aging-Us, 2019, 卷号: 11, 期号: 23, 页码: 11054-11072
作者:  Y.Liu;  Y.H.Zhou;  K.H.Huang;  Y.Li;  X.J.Fang
收藏  |  浏览/下载：2/0  |  提交时间：2020/08/24
Phase I/II Trial of Multi-Target Chimeric Antigen Receptor Modified T Cells (4SCAR2.0) Against Relapsed or Refractory Lymphomas 期刊论文
BLOOD, 2018, 卷号: 132
作者:  Chang, Lung-Ji;  Li, Yuhua;  Tu, Sanfang;  Lai, Xun;  Huang, Rui
收藏  |  浏览/下载：20/0  |  提交时间：2019/12/04
Optimized DNA electroporation for primary human T cell engineering 期刊论文
BMC BIOTECHNOLOGY, 2018, 卷号: Vol.18
作者:  Chen, Wei;  Qiu, Shunfang;  Zhang, Xiaopeng;  Zhang, Zhang
收藏  |  浏览/下载：7/0  |  提交时间：2019/04/24
Metformin inhibits proliferation and cytotoxicity and induces apoptosis via AMPK pathway in CD19-chimeric antigen receptor-modified T cells 期刊论文
ONCOTARGETS AND THERAPY, 2018, 卷号: 11, 页码: 1767-1776
作者:  Mu, Qian;  Jiang, Miao;  Zhang, Yuzhu;  Wu, Fei;  Li, Hui
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/11
EphA2 chimeric antigen receptor-modified T cells for the immunotherapy of esophageal squamous cell carcinoma 期刊论文
JOURNAL OF THORACIC DISEASE, 2018, 卷号: 10, 期号: 5, 页码: 2779-2788
作者:  Shi, Hui[1];  Yu, Feng[2];  Mao, Yinting[3];  Ju, Qianqian[4];  Wu, Yingcheng[5]
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/24
Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified Anti-MUC1 chimeric antigen receptor transduced T cells 期刊论文
SCIENCE CHINA-LIFE SCIENCES, 2016, 卷号: 59, 期号: [db:dc_citation_issue], 页码: 386-397
作者:  You, Fengtao;  Jiang, Licui;  Zhang, Bozhen;  Lu, Qiang;  Zhou, Qiao
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/02
Erratum: Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA 期刊论文
Cell discovery, 2016
Bai Yun; Kan Shifeng; Zhou Shixin; Wang Yuting; Xu Jun; Cooke John P; Wen Jinhua; Deng Hongkui
收藏  |  浏览/下载：3/0  |  提交时间：2017/12/04
Safety and Efficacy Evaluation of 4SCAR19 Chimeric Antigen Receptor-Modified T Cells Targeting B Cell Acute Lymphoblastic Leukemia - Three-Year Follow-up of a Multicenter Phase I/II Study 会议论文
作者:  Chang, Lung-Ji;  Dong, Lujia;  Liu, Yu-Chen;  Tsao, Shih-Ting;  Li, Ya-Chen
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/06
Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA 期刊论文
Cell discovery, 2015
Bai Yun; Kan Shifeng; Zhou Shixin; Wang Yuting; Xu Jun; Cooke John P; Wen Jinhua; Deng Hongkui
收藏  |  浏览/下载：6/0  |  提交时间：2017/12/04

©版权所有 ©2017 CSpace - Powered by CSpace